Paul Latimer

Paul Latimer, PhD, has extensive experience in oncology and molecular genetics, with significant roles in research and medical affairs. At The University of Texas at Austin, Paul served as Research Team Leader analyzing the effects of a vitamin E derivative in cancer treatment and as an Academic Fellow studying apoptotic signaling pathways. Paul transitioned to Genentech as a Senior Medical Science Liaison and held several leadership positions, receiving multiple ACE Awards for excellence. Subsequent roles included Field Director and imCORE Scientific Alliance Relationship Manager at Roche, and Oncology Medical Science Liaison at Eli Lilly, where Paul was instrumental in fostering relationships with key opinion leaders and managing clinical research initiatives. Paul holds a PhD in Cancer Biology/Oncology and has contributed to genetic education as a lecturer.